Plain-English translation of NCT06847373 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether taking a higher daily dose of cholecalciferol (vitamin D) can help improve insulin resistance in young people with obesity. Researchers will compare two groups: one receiving 4000 IU of the medication daily, and another receiving 1000 IU daily, over six months. The goal is to see if this treatment can help the body use insulin more effectively.
Many young people with obesity have trouble with insulin resistance, which means their bodies don't respond well to insulin and can lead to serious health problems like diabetes. Some research suggests that vitamin D may help improve how the body handles insulin, so this trial aims to find out if increasing vitamin D levels can make a real difference.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either a higher dose or lower dose of vitamin D as a daily pill for six months. You'll visit the hospital for check-ins where doctors will measure your weight, take blood tests to check your insulin levels, and ask about how you're feeling. The entire study lasts six months, and you'll need to be consistent about taking your daily supplement.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Mexico